Ipca Laboratories informs about company updates

24 Aug 2019

Ipca Laboratories has informed that the US FDA conducted the inspection of the Company’s Formulations manufacturing Unit situated at Piparia (Silvassa) from 19th August, 2019 to 23rd August, 2019. At the conclusion of the inspection, the US FDA issued a Form 483 with 3 observations. 

The above information is a part of company’s filings submitted to BSE.

Related Ipca Laboratories Ltd. Links:

Ipca Laboratories Share Price

1961.25 55.10 (2.89%) Mar 03, 18:59
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 624.15
Dr. Reddys Lab 4500.80
Lupin 1060.85
Piramal Enterprises 1992.70
Cadila Healthcare 445.50
View more..
Sensex vs Ipca Laboratories
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback